| |
|
|
|
Antares Pharma  
|
|
2.79 0.01 (0%) |
09-22 16:00 |
|
Open: |
2.8 |
Pre close: |
2.78 |
Target:
|
3.43 
|
|
High: |
2.815 |
Low: |
2.75 |
Resistance:
|
2.94
3.43
|
|
Volume: |
417,785 |
Market Cap: |
463M |
Support:
|
2.71
2.57
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.79
|
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
2.75 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
2.80  |
Stochastic Oscillator |
%K(14,3):
|
72.45 |
|
MA(250): |
3.28 |
%D(3): |
69.67 |
|
Average Volume(K) |
3-Month: |
92061
|
52-Week |
High:
|
5.13 |
|
10-Days: |
92976 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
50.87 |
Change(%): |
-22.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.034 |
Return on Equity (ttm) |
11.2 |
Shares Out. (M) |
166.09 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
4.6 |
Shares Float (M) |
153.40 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.45 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
13.9 |
% Held by Institutions |
41.63 |
|
Forward EPS |
-0.010 |
Gross Profit (p.s.) |
0.442 |
Shares Short (K) |
4560 |
|
Book Value (p.s.) |
0.340 |
EBITDA (p.s.) |
0.070 |
P/E |
82.06 |
|
Sales Per Share |
0.829 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.21 |
|
Profit Margin |
4.04 |
Operating Cash Flow
(M) |
9.83 |
P/S |
3.37 |
|
Operating Margin |
6.71 |
Levered Free Cash Flow
(M) |
7.88 |
P/CF |
47.14 |
|
|
|
|
|
|
